Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

54 results about "Cotransformation" patented technology

Cotransformation is the simultaneous transformation of two or more genes. Only genes in the same chromosomal vicinity can be transformed; the closer together the genes lie, the more frequently they will be cotransformed. By contrast, genes sufficiently far apart that they cannot appear together on a fragment of foreign DNA will almost never be cotransformed, because transformation is so inefficient that recipient cells usually take up only a single DNA.

Construction method of genetically engineered bacterium for producing beta-carotene

The invention discloses a construction method of genetically engineered bacterium for producing beta-carotene, which is characterized by comprising the following steps: A)constructing a gene expression module, wherein the gene expression module comprises relative gene for producing beta-carotene, a promoter at the upstream of relative gene for producing beta-carotene and a terminator at the downstream of the relative gene for producing beta-carotene; and B)performing cotransformation of the gene expression module to saccharomyces cerevisiae. The method has the advantages of simple, rapid and high efficiency performance, multi-grade clone is avoided, restriction enzyme cutting site is not required for depending on, multiple fragments enable cotransformation, the homologous recombination efficiency is high, and the engineering bacteria construction time can be obviously shortened.
Owner:SHANGHAI LAIYI BIOMEDICAL RES & DEV CENT +1

Engineering bacterium, construction thereof and method for preparing D-valine by using the same

The invention provides an engineering strain, which can simultaneously express D-hydantoin enzyme and N-carbamoyl-D-amino amidohydrolase. The construction method of the invention is as follows: a D-hydantoin enzyme gene is cloned to a plasmid ET-28a and an N-carbamoyl-D-amino amidohydrolase gene is cloned to a plasmid pQE-30, and then two recombinant plasmids pET28a-hyd and pQE30-cab are shifted into the same Escherichia coli cell by utilization of a co-conversion technology. The invention also provides a method for producing D-valines by utilization of the engineering strain to convert 5'-opropyl hydantoin. The method is characterized by high optical purity of products, simple manufacturing technique, and environmental protection and so on; moreover, compared with the prior market products, the method is low in production cost.
Owner:SHANXI UNIV

Method for converting disease-resistance genes of rice and obtaining transgenic descendants without selective markers

The invention relates to a method for converting disease-resistance genes of rice and obtaining transgenic descendants without selective markers. The method comprises the following steps: first, cloning green fluorescent protein (GFP) and hygromycin phosphotransferase (HPT) on a marker gene carrier, placing a target gene in other T-DNA carrier, mixing strains of agrobacterium tumefaciens carrying the marker gene carrier and strains of agrobacterium tumefaciens carrying the target gene carrier and converting callus of the rice, performing PCR (polymerase chain reaction) detection on the disease-resistance genes of the target gene carrier by a specific primer, and screening to obtain co-transformation plants (T0); then, screening the marker gene plants with positive GFP rapidly and massively by means of a desk lamp fluorescence detector in segregative generations (T1 or T2) of the co-transformation plant for removing, and performing PCR detection for disease-resistance genes to the plants with negative GFP so as to obtain the individuals without selective markers of the transgenic disease-resistance genes. The method can be applied to transgenic breeding without selective markers of rice blast-resistant genes or other functional genes of the rice, and enhances the disease resistance of the rice or improves other agronomic traits.
Owner:ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES

Method for producing trans-4-hydroxyproline from glucose in fermentation manner

The invention discloses a method for producing trans-4-hydroxyproline from glucose in a fermentation manner by virtue of recombinant Escherichia coli without adding exogenous L-proline. A recombinant plasmid carried by the recombinant Escherichia coli has a mutant gene proBA2 and hyp (4-hydroxyproline), wherein proBA2 is mutated on a glutamyl kinase encoding gene proB, and the inhibition effect of L-proline on glutamyl kinase encoded by the mutated gene is remarkably reduced. proBA2 and hyp are co-expressed, and trans-4-hydroxyproline can be produced directly from glucose in the fermentation manner without adding exogenous L-proline. The recombinant plasmid is obtained by recombining proBA2 and hyp onto the same expression plasmid or by co-transforming recombinant plasmids which contain the two genes respectively and have different resistances. The invention further discloses the application of the Escherichia coli to the production of hydroxyproline.
Owner:JIANGNAN UNIV

ING4 and OSM double-gene co-expression vector and application thereof

The invention belongs to the field of adenovirus vectors and in particular discloses a recombinant adenovirus vector Ad-ING4-OSM and a preparation method thereof. The preparation method comprises the following steps: on the basis of a transfer plasmid pAdTrack-CWV-polyA-promoter, inserting an ING4 segment between BglII and SalI polyclonal sites of the transfer plasmid and inserting an OSM segment between NOtI and HindIII restriction sites of the transfer plasmid so as to prepare a recombinant transfer plasmid pAdTrack-CWV-ING4-poly-A-promoter-OSM; carrying out co-transformation on the recombinant transfer plasmid and a pAsEasy-1 adenovirus skeleton plasmid to BJ5183 competence bacteria with a calcium chloride method; screening, carrying out PacI restriction, and transfecting QBI-293A cells with a liposome; and carrying out multi-time infection and amplification so as to obtain the recombinant adenovirus vector Ad-ING4-OSM. Compared with the Ad-ING4 and Ad-OSM single genomes, the recombinant adenovirus vector Ad-ING4-OSM shows obvious tumor-inhibiting synergy and radiotherapy sensitizing synergistic effect on human laryngocarcinoma Hep-2 cells and nude mouse transplanted tumor thereof and shows superimposed anticancer synergy for inhibiting growth of SPC-A1 pulmonary adenocarcinoma cells and inducing apoptosis.
Owner:SUZHOU UNIV

Method for constructing target protein interaction network based on high-throughput sequencing

ActiveCN112301117ASimple stepsSolve the problem of missing potential interacting proteinsMicrobiological testing/measurementHybridisationReference genesProtein target
The invention discloses a method for constructing a target protein interaction network based on high-throughput sequencing. According to the method, a BD-bait and a prey library are co-transformed into a Y2H yeast strain, then culturing in a YPDplus culture medium at 30 DEG C for 4 hours, discarding the supernatant, adding 1mL of sterile water medium for suspension, taking 100muL of suspension bacterial liquid and adding into 10ml of SD / -Leu / -Trp / -His / -Ade liquid culture medium for shaking culture, sampling respectively after shaking culture for 24 hours, 72 hours and 80 hours, the sampled bacterial liquids are used as templates for PCR (Polymerase Chain Reaction) amplification, carrying out agarose gel electrophoresis to test the screening degree of the bacterial liquids, recycling products, carrying out high-throughput sequencing, carrying out gene abundance and difference analysis after de novo assembly, and taking a difference gene as a protein coding gene interacting with a targetgene in the library, so as to preliminarily construct an interaction network of the target protein. The method is also suitable for constructing a target protein interaction network of species without reference genes. The method simplifies the steps of a yeast two-hybrid screening library, and the method is not limited by the number of clones screened once, and can find all interaction proteins of a target protein in a single library.
Owner:NANJING AGRICULTURAL UNIVERSITY

Phage-assisted cellooligosaccharide transporter continuous directed evolution system and method

The invention provides a bacteriophage-assisted cellooligosaccharide transporter continuous directed evolution system and a bacteriophage-assisted cellooligosaccharide transporter continuous directed evolution method. The directed evolution system comprises AV1 plasmid, AV2 plasmid and bacteriophage, and nucleotide sequences of the AV1 plasmid and the AV2 plasmid are respectively shown as SEQ ID NO.7 and SEQ ID NO.8. The invention further provides a preparation method of the bacteriophage-assisted cellooligosaccharide transporter continuous directed evolution system. The method for directed evolution of the cello-oligosaccharide transporter comprises the following steps: co-transforming AV1 plasmid and AV2 plasmid into host bacteria to obtain engineering bacteria for evolution; the phage and the engineering bacteria for evolution obtained in the step 1 are subjected to multiple rounds of evolution culture in a culture medium containing the cellooligosaccharide, in the multiple rounds of evolution culture process, the concentration of the cellooligosaccharide in the culture medium is decreased progressively so as to increase the screening pressure, and the mutant protein is obtained. The invention designs a visual bacteriophage-assisted continuous directed evolution system, the system comprises AV1 plasmid and AV2 plasmid, the visual high-throughput evolution process of the cello-oligosaccharide transporter can be realized by adopting the evolution system to evolve the cello-oligosaccharide transporter, excessive human intervention is avoided, the evolution efficiency is higher and more sensitive, and the method is suitable for large-scale popularization and application. Further, the transport capacity of the LacY on the cellooligosaccharides is greatly improved.
Owner:GUANGZHOU INST OF ADVANCED TECH CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products